Versameb

Sensible Biotechnologies

This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.

ExcepGen

ExcepGen develops a platform for nucleic acid therapeutics to improve the efficacy and tolerability of mRNA-based medicines for biopharmaceutical companies.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Veritas In Silico

The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.

Engage Bio

This biotechnology company develops non-viral genetic medicines and mRNA immunotherapies for pharmaceutical partners to treat cancer and gene replacement disorders.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.